Evidence map›Paper›PMID 39158758›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2024

The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity.

Eduardo Duarte-Silva, Alice Chevrollier Oriá, Ingrid Prata Mendonça, Igor Henrique Rodrigues Paiva, Klyvia Leuthier Dos Santos, Amanda Juliana Sales, José Roberto Botelho de Souza, Michael Maes, Sven Guenther Meuth, Christina Alves Peixoto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eduardo Duarte-SilvaLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil. eduardo.pduartesilva@gmail.com.
Alice Chevrollier OriáLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil.
Ingrid Prata MendonçaLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil.
Igor Henrique Rodrigues PaivaLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil.
Klyvia Leuthier Dos SantosLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil.
Amanda Juliana SalesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
José Roberto Botelho de SouzaDepartment of Zoology, Federal University of Pernambuco, Recife, PE, Brazil.
Michael MaesDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Sven Guenther MeuthDepartment of Neurology, University Hospital Düsseldorf, 40255, Düsseldorf, Germany.
Christina Alves PeixotoLaboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, PE, Brazil. peixoto.christina@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Sclerosis (MS) is a debilitating disease that severely affects the central nervous system (CNS). Apart from neurological symptoms, it is also characterized by neuropsychiatric comorbidities, such as anxiety and depression. Phosphodiesterase-5 inhibitors (PDE5Is) such as Sildenafil and Tadalafil have been shown to possess antidepressant-like effects, but the mechanisms underpinning such effects are not fully characterized. To address this question, we used the EAE model of MS, behavioral tests, immunofluorescence, immunohistochemistry, western blot, and 16 S rRNA sequencing. Here, we showed that depressive-like behavior in Experimental Autoimmune Encephalomyelitis (EAE) mice is due to neuroinflammation, reduced synaptic plasticity, dysfunction in glutamatergic neurotransmission, glucocorticoid receptor (GR) resistance, increased blood-brain barrier (BBB) permeability, and immune cell infiltration to the CNS, as well as inflammation, increased intestinal permeability, and immune cell infiltration in the distal colon. Furthermore, 16 S rRNA sequencing revealed that behavioral dysfunction in EAE mice is associated with changes in the gut microbiota, such as an increased abundance of Firmicutes and Saccharibacteria and a reduction in Proteobacteria, Parabacteroides, and Desulfovibrio. Moreover, we detected an increased abundance of Erysipelotrichaceae and Desulfovibrionaceae and a reduced abundance of Lactobacillus johnsonii. Surprisingly, we showed that Tadalafil likely exerts antidepressant-like effects by targeting all aforementioned disease aspects. In conclusion, our work demonstrated that anxiety- and depressive-like behavior in EAE is associated with a plethora of neuroimmune and gut microbiota-mediated mechanisms and that Tadalafil exerts antidepressant-like effects probably by targeting these mechanisms. Harnessing the knowledge of these mechanisms of action of Tadalafil is important to pave the way for future clinical trials with depressed patients.

Indexed as

Anti-Anxiety AgentsAntidepressive AgentsBrain-Gut AxisDepressionEncephalomyelitis, Autoimmune, ExperimentalPhosphodiesterase 5 InhibitorsTadalafilAnimalsAutoimmunityFemaleGastrointestinal MicrobiomeMiceMice, Inbred C57BLAnti-Anxiety AgentsAntidepressive AgentsPhosphodiesterase 5 InhibitorsTadalafilAnxietyExperimental Autoimmune Encephalomyelitis (EAE)Gut microbiotaMajor depressive disorderMicrobiota-gut-brain axisMultiple Sclerosis (MS)Phosphodiesterase-5 inhibitorTadalafil

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.